The American Academy of Orthopaedic
Surgeons
website has a Public Information section on osteoporosis at: http://www.aaos.org/wordhtml/pat_educ/osteo98.htm.
Eli Lilly and Company
(http://www.evista.com/),
the manufacturer of the drug, Evista (generic name, raloxifene), provides basic
information on osteoporosis as well as full prescribing information on Evista. Eli Lilly
and Company discusses the variety of benefits and risks associated with Evista. To learn
more about Evista, call 1.888.384.7823.
EndocrineWeb.com (http://www.endocrineweb.com/) is a
comprehensive website with information on the body’s endocrine system and glands,
endocrine surgery and thyroid, parathyroid, and adrenal gland functions and abnormalities.
Full color, easy-to-understand diagrams help explain complex biological processes. The
site also offers extensive information on diabetes, osteoporosis, and endocrine diseases
of the pancreas. Users may search the EndocrineWeb index to find a
surgeon or medical specialist (endocrinologist) in a particular city.
Fore (Foundation For
Osteoporosis Research And Education) is a non-profit organization which provides
information on the diagnosis and treatment of osteoporosis at http://www.fore.org/.
Users may also sign up for a quarterly newsletter on osteoporosis for a small annual fee.
Fore provides educational lectures on osteoporosis and related women's health issues to
community groups, professional organizations, and corporate offices free of charge. Groups
interested in scheduling a lecture may call 510.832.2663 (510.832.BONE).
Merck & Co. (http://www.merck.com/),
the manufacturer of the drug, Fosamax (generic name, alendronate), provides basic
information on using Fosamax to treat osteoporosis. The information on this site is
tailored more for physicians than for patients.
The
National Osteoporosis Foundation
(NOF) is a non-profit organization and may be reached at 1.800.223.9994. The NOF is a
leading resource for people seeking up-to-date, medically sound information on the causes,
prevention, detection and treatment of osteoporosis. The NOF provides detailed information
about osteoporosis at their website: www.nof.org.
Norvartis Pharmaceuticals Company
(http://www.pharma.us.novartis.com/), the
manufacturer of the drug, Miacalcin (generic name, calcitonin) provides information on
treating osteoporosis with Miacalcin. Norvartis discusses how to take Miacalcin
effectively as well as all possible side effects to the medication. Users should be aware
that this site provides technical information on Miacalcin that may not be helpful for
patients who know little about the drug.
OsNET, Inc. is a non-profit,
membership-driven network specializing in clinical research for the pharmaceutical
industry in Osteoporosis, Musculo-Skeletal Disease, and Women's Health. OsNET is comprised
of twenty one high quality healthcare locations in the US. The mission of OsNET is to
advance clinical research by linking centers of excellence with study sponsors and CROs
(clinical research organizations). www.osnet.org
The Osteoporosis and Related Bone
Diseases National Resource Center seeks to create an awareness of osteoporosis,
Paget's disease, and osteogenesis imperfecta, and of the general possibilities for
therapy. They provide an informational website for both the general public and physicians
at www.osteo.org.
The Osteogenesis Imperfecta
Foundation (OIF) is a voluntary national health organization dedicated to helping
people cope with the problems associated with Osteogenesis Imperfecta. The OIF maintains
an informative website at www.oif.org.
The Physicians’ Desk Reference
(PDR) website (http://www.pdr.net/ ) provides
detailed information on osteoporosis including an explanation of the disease, risk factors
and warning signs, diagnosis, prevention, treatment, and survival. The PDR website has
also created a separate section on osteoporosis for physician reference. Users may test
their knowledge of osteoporosis by taking a mini-test.
